Medivir: Rights Issue Funds New Phase II - Redeye
Bildkälla: Stockfoto

Medivir: Rights Issue Funds New Phase II - Redeye

Redeye comments on the rights issue announced today and the new study design. We revise our base case based on the new path to market and dilution expected from the rights issue.

Redeye comments on the rights issue announced today and the new study design. We revise our base case based on the new path to market and dilution expected from the rights issue.
Börsvärldens nyhetsbrev